Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi S&P World Financials Screened UCITS ETF Dist
WELY · IE000ENYES77 · class UCITS ETF Dist · EUR · domicile Ireland
Equity · Global · Financials · Sustainable / ESGSFDR art. 8
Index tracked: S&P World Financials Weighted & Screened Index
- TER
- 0.18%+ trans. 0.07%
- Fund size
- 32 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 20 Sept 2022 · costs from the KID as of 2 Sept 2026 · 210 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is passively managed. The objective of the Sub-Fund is to track the performance of the S&P World Financials Weighted & Screened Index (the "Index"). The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Sub-Fund promotes environmental and/or social characteristics through among others, replicating an Index integrating an environmental, social and governance ("ESG") rating. The Index is an equity index that measures the performance of eligible equity securities from…
Performance since series start (in euro) — base 100
20 Sept 2022 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +23.5% |
| 3 years | +94.5% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +103.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.93% | 13.16% | — |
| Max drawdown | −11.58% | −19.62% | — |
| Sharpe | 1.43 | 1.32 | — |
| Sortino | 2.06 | 1.79 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · WELY · IE000ENYES771
RebalixWELY · IE000ENYES77 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.59% | +15.45% | +0.14% |
| 2024 | +34.79% | +34.61% | +0.19% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 0.358 EUR (1.88% of NAV) · last ex-date 10 Feb 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 1 | 0.358 | — |
| 2025 | 1 | 0.344 | +2.30% |
| 2024 | 1 | 0.2286 | +2.02% |
| 2023 | 1 | 0.0286 | +0.28% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 210 securities · top-10 weight = 31.3%
| Top holdings | Weight |
|---|---|
| 7.2% | |
| 4.8% | |
| 3.7% | |
| 3.0% | |
| 2.5% | |
| 2.2% | |
| 2.1% | |
| 2.1% | |
| 2.0% | |
| 1.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
WEL8 · Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000ENYES77
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000ENYES77
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · WELY · IE000ENYES772